HIV capsid protein — Drug Target

All drugs that target HIV capsid protein — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

HIV capsid inhibitor

Marketed (1)

• Lenacapavir long-acting · ViiV Healthcare · HIV capsid inhibitor · Infectious Disease
  Lenacapavir is a first-in-class HIV capsid inhibitor that binds to the HIV capsid protein and blocks the uncoating of viral RNA, preventing early steps of HIV replication.

Phase 3 pipeline (1)

• Lenacapavir Injection · Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida · HIV capsid inhibitor · Infectious Disease
  Lenacapavir is a first-in-class HIV capsid inhibitor that prevents the uncoating of HIV viral particles, blocking early steps of viral replication.